Global Thematic Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-108,540
Closed -$34M 56
2017
Q3
$34M Buy
108,540
+3,419
+3% +$1.01M 1.09% 45
2017
Q2
$28.5M Buy
105,121
+18,050
+21% +$4.77M 0.92% 41
2017
Q1
$23.8M Buy
87,071
+14,684
+20% +$4.15M 0.81% 52
2016
Q4
$20.5M Sell
72,387
-25,851
-26% -$7.66M 0.69% 50
2016
Q3
$30.8M Sell
98,238
-13,364
-12% -$3.96M 0.92% 45
2016
Q2
$27M Buy
111,602
+9,881
+10% +$2.6M 0.67% 49
2016
Q1
$26.5M Buy
+101,721
New +$26.9M 0.57% 59

Other funds holding BIIB

Global Thematic Partners's BIIB Position: Q4 2017 in Review

Global Thematic Partners sold out of Biogen (BIIB) in Q4 2017, closing a stake of 108,540 shares — an estimated $34M sold.

Global Thematic Partners first reported a position in BIIB in Q1 2016 and held it in 7 quarters. The position peaked at $34M in Q3 2017. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Global Thematic Partners reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Global Thematic Partners sold 108,540 Biogen shares in Q4 2017, an estimated $34M.
  • Global Thematic Partners first reported a position in Biogen in Q1 2016 and held it in 7 quarters.
  • Global Thematic Partners's Biogen position peaked at $34M in Q3 2017.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Global Thematic Partners's 13F filing for Q4 2017, filed 29 Jan 2018.